UCI MIND Scientist and Caregiver on Alzheimer’s


  more >

Cancer drug rapidly clears amyloid plaques

Researchers at Case Western Reserve University School of Medicine have demonstrated that bexarotene, an FDA-approved drug for the  treatment of skin cancer, dramatically and rapidly clears amyloid plaques from the brains of mice bred with Alzheimer’s disease.  Led by Gary Landreth, Ph.D.,  the study just published on line in Science Express, found that bexarotene not only enhanced clearance of beta amyloid, an abnormal protein associated with Alzheimer’s disease, but also improved some cognitive and behavioral functions. more >

UCI Teaser Video

Trailer video for the full version of a documentary that looks at what UCI is doing to fight Alzheimer’s disease.

Obama boosts Alzheimer's funding by $130 million

Kathleen Sebelius, Secretary of Health and Human Services, announced today that the Obama administration would increase funding for Alzheimer’s disease research by $130 million.   An extra $50 million will be made available immediately, and another $80 million will be added to the fiscal year 2013 federal budget to be released next week.  In total, this funding represents a 25% increase in funding for Alzheimer’s disease research over the next two years.  An additional $25 million will be allocated for caregiver support, provider education, public awareness, and improvements in data infrastructure.  “We can’t wait to confront the growing threat that Alzheimer’s disease poses to American families and to our nation as a whole,” noted Sebelius.   Increased funding comes on the heels of the recent announcement that first goal of  the National Alzheimer’s Project Act is

to prevent and effectively treat Alzheimer’s disease by 2025

Nationwide, 5.4 million people have AD and rely on 14.9 million close family members and friends for care.  In California, AD currently affects nearly 500,000 people, a number that is expected to escalate to 1.1 million by 2030.  With an average of three caregivers supporting each of these 1.1 million people, the number of Californians coping with AD will total an estimated 4.4 million in 2030. more >

Aimee Pierce, M.D., Named Medical Director

Dr. Aimee Pierce, Assistant Clinical Professor in UCI’s Department of Neurology, has been named Medical Director of the UCI MIND Memory Assessment Clinic.  Hailing from Eugene, Oregon, Dr. Pierce earned her B.S. in Biology at the California Institute of Technology in Pasadena, CA, and her M.D. more >